arrow
P

Pablo C. Okhuysen

The University of Texas MD Anderson Cancer Center
H指数:53
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis

免疫检查点抑制前的胃肠道感染会阻碍治疗效果并增加结肠炎的风险

2025-08-100
OA
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response

Ridinilazole与万古霉素治疗艰难梭菌感染的随机,双盲,3期安全性和有效性研究: 微生物组和代谢组与反应相关的临床结果

2024-02-028
OAAI
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

调节益生元食物来源影响炎症和免疫调节肠道微生物和代谢物: 来自BE GONE试验的见解

2023-12-0110
OAAI
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment

饮食衍生的代谢物和粘液将肠道微生物组与细胞毒性癌症治疗后的发热联系起来

2022-11-1628
OA
Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure
2022-09-017
OAAI
Fully resolved assembly of Cryptosporidium parvum
2022-02-156
OAAI
Telomere dysfunction activates YAP1 to drive tissue inflammation
2020-09-2155
OAAI
Telomere dysfunction is a driver of inflammatory bowel disease
2019-07-010
PRE